Abdel-Azeem Amal S, Hegazy Amany M, Ibrahim Khadiga S, Farrag Abdel-Razik H, El-Sayed Eman M
Department of Food Science & Nutrition, National Research Centre, Dokki, Cairo, Egypt.
J Diet Suppl. 2013 Sep;10(3):195-209. doi: 10.3109/19390211.2013.822450. Epub 2013 Aug 9.
Ginger is a remedy known to possess a number of pharmacological properties. This study investigated efficacy of ginger pretreatment in alleviating acetaminophen-induced acute hepatotoxicity in rats. Rats were divided into six groups; negative control, acetaminophen (APAP) (600 mg/kg single intraperitoneal injection); vitamin E (75 mg/kg), ginger (100 mg/kg), vitamin E + APAP, and ginger + APAP. Administration of APAP elicited significant liver injury that was manifested by remarkable increase in plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), arginase activities, and total bilirubin concentration. Meanwhile, APAP significantly decreased plasma total proteins and albumin levels. APAP administration resulted in substantial increase in each of plasma triacylglycerols (TAGs), malondialdhyde (MDA) levels, and total antioxidant capacity (TAC). However, ginger or vitamin E treatment prior to APAP showed significant hepatoprotective effect by lowering the hepatic marker enzymes (AST, ALT, ALP, and arginase) and total bilirubin in plasma. In addition, they remarkably ameliorated the APAP-induced oxidative stress by inhibiting lipid peroxidation (MDA). Pretreatment by ginger or vitamin E significantly restored TAGs, and total protein levels. Histopathological examination of APAP treated rats showed alterations in normal hepatic histoarchitecture, with necrosis and vacuolization of cells. These alterations were substantially decreased by ginger or vitamin E. Our results demonstrated that ginger can prevent hepatic injuries, alleviating oxidative stress in a manner comparable to that of vitamin E. Combination therapy of ginger and APAP is recommended especially in cases with hepatic disorders or when high doses of APAP are required.
生姜是一种已知具有多种药理特性的药物。本研究调查了生姜预处理对减轻大鼠对乙酰氨基酚诱导的急性肝毒性的功效。大鼠被分为六组:阴性对照组、对乙酰氨基酚(APAP)(600mg/kg单次腹腔注射);维生素E(75mg/kg)、生姜(100mg/kg)、维生素E + APAP以及生姜 + APAP。给予APAP引发了显著的肝损伤,表现为血浆丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、精氨酸酶活性以及总胆红素浓度显著升高。同时,APAP显著降低了血浆总蛋白和白蛋白水平。给予APAP导致血浆三酰甘油(TAGs)、丙二醛(MDA)水平以及总抗氧化能力(TAC)均大幅增加。然而,在给予APAP之前进行生姜或维生素E治疗通过降低肝脏标志物酶(AST、ALT、ALP和精氨酸酶)以及血浆总胆红素显示出显著的肝脏保护作用。此外,它们通过抑制脂质过氧化(MDA)显著改善了APAP诱导的氧化应激。生姜或维生素E预处理显著恢复了TAGs以及总蛋白水平。对接受APAP治疗的大鼠进行组织病理学检查显示正常肝脏组织结构发生改变,细胞出现坏死和空泡化。生姜或维生素E使这些改变大幅减少。我们的结果表明,生姜可以预防肝脏损伤,以与维生素E相当的方式减轻氧化应激。尤其在患有肝脏疾病或需要高剂量APAP的情况下,建议采用生姜与APAP的联合治疗。